Interleukin-1β plays key roles in LPA-induced amplification of LPA production in neuropathic pain model

Cellular and Molecular Neurobiology

Volumn 33, Issue 8, 2013, Pages 1033-1041

  Yano, Ryo ^a   Ma, Lin ^a   Nagai, Jun ^a   Ueda, Hiroshi ^a  

^a NAGASAKI UNIVERSITY   (Japan)

Author keywords

Interleukin 1 ; Lysophosphatidic acid; MALDI TOFMS; Neuropathic pain

Indexed keywords

CALCIUM INDEPENDENT PHOSPHOLIPASE A2; CYTOKINE ANTIBODY; CYTOSOLIC PHOSPHOLIPASE A2; INTERLEUKIN 1BETA; LYSOPHOSPHATIDIC ACID; MESSENGER RNA; NEUTRALIZING ANTIBODY;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BEHAVIOR CHANGE; CONTROLLED STUDY; CYTOKINE RELEASE; DISEASE MODEL; ENZYME ACTIVATION; ENZYME ASSAY; GENE EXPRESSION; LIPID ANALYSIS; LYSOPHOSPHATIDIC ACID PRODUCTION; MALE; MASS SPECTROMETRY; MOUSE; NEUROPATHIC PAIN; NONHUMAN; PHOSPHOLIPID SYNTHESIS; PRIORITY JOURNAL; PROTEIN FUNCTION; QUANTITATIVE ANALYSIS; SPINAL CORD DORSAL HORN;

ANIMALS; ANTIBODIES, NEUTRALIZING; DISEASE MODELS, ANIMAL; GENE EXPRESSION REGULATION; GROUP IV PHOSPHOLIPASES A2; INTERLEUKIN-1BETA; LYSOPHOSPHOLIPIDS; MALE; MICE; MICE, INBRED C57BL; NEURALGIA; PHOSPHOLIPASES A2, CALCIUM-INDEPENDENT; POSTERIOR HORN CELLS; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION;

EID: 84886400150     PISSN: 02724340     EISSN: 15736830     Source Type: Journal    
DOI: 10.1007/s10571-013-9970-3     Document Type: Article

References (51)

1. Ahn DK, Lee SY, Han SR, Ju JS, Yang GY, Lee MK, Youn DH, Bae YC (2009) Intratrigeminal ganglionic injection of LPA causes neuropathic pain-like behavior and demyelination in rats. Pain 146:114-120
2. Aoki J (2004) Mechanisms of lysophosphatidic acid production. Semin Cell Dev Biol 15:477-489
3. Aoki J, Taira A, Takanezawa Y et al (2002) Serum lysophosphatidic acid is produced through diverse phospholipase pathways. J Biol Chem 277:48737-48744
4. Aoki J, Inoue A, Okudaira S (2008) Two pathways for lysophosphatidic acid production. Biochim Biophys Acta 1781:513-518
5. Chan LC, Peters W, Xu Y, Chun J, Farese RV Jr, Cases S (2007) LPA3 receptor mediates chemotaxis of immature murine dendritic cells to unsaturated lysophosphatidic acid (LPA). J Leukoc Biol 82:1193-1200
6. Choi JW, Chun J (2013) Lysophospholipids and their receptors in the central nervous system. Biochim Biophys Acta 1831:20-32
7. Choi JW, Herr DR, Noguchi K et al (2010) LPA receptors: subtypes and biological actions. Annu Rev Pharmacol Toxicol 50:157-186
8. Eder C (2009) Mechanisms of interleukin-1beta release. Immunobiology 214:543-553
9. Goldshmit Y, Munro K, Leong SY, Pebay A, Turnley AM (2010) LPA receptor expression in the central nervous system in health and following injury. Cell Tissue Res 341:23-32
10. Gupta GP, Massague J (2004) Platelets and metastasis revisited: a novel fatty link. J Clin Investig 114:1691-1693
11. Hanada M, Sugiura Y, Shinjo R, Masaki N, Imagama S, Ishiguro N, Matsuyama Y, Setou M (2012) Spatiotemporal alteration of phospholipids and prostaglandins in a rat model of spinal cord injury. Anal Bioanal Chem 403:1873-1884
12. Hargreaves K, Dubner R, Brown F, Flores C, Joris J (1988) A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia. Pain 32:77-88
13. Hayashi Y, Kawaji K, Sun L, Zhang X, Koyano K, Yokoyama T, Kohsaka S, Inoue K, Nakanishi H (2011) Microglial Ca(2+)-activated K(+) channels are possible molecular targets for the analgesic effects of S-ketamine on neuropathic pain. J Neurosci 31:17370-17382
14. Hylden JL, Wilcox GL (1980) Intrathecal morphine in mice: a new technique. Eur J Pharmacol 67:313-316
15. Inoue M, Rashid MH, Fujita R, Contos JJ, Chun J, Ueda H (2004) Initiation of neuropathic pain requires lysophosphatidic acid receptor signaling. Nat Med 10:712-718
16. Inoue M, Ma L, Aoki J, Ueda H (2008) Simultaneous stimulation of spinal NK1 and NMDA receptors produces LPC which undergoes ATX-mediated conversion to LPA, an initiator of neuropathic pain. J Neurochem 107:1556-1565
17. Kashimoto R, Yamanaka H, Kobayashi K, Okubo M, Yagi H, Mimura O, Noguchi K (2013) Phosphorylation of ezrin/radixin/moesin (ERM) protein in spinal microglia following peripheral nerve injury and lysophosphatidic acid administration. Glia 61:338-348
18. Kawasaki Y, Xu ZZ, Wang X et al (2008) Distinct roles of matrix metalloproteases in the early- and late-phase development of neuropathic pain. Nat Med 14:331-336
19. Lee HL, Lee KM, Son SJ, Hwang SH, Cho HJ (2004) Temporal expression of cytokines and their receptors mRNAs in a neuropathic pain model. NeuroReport 15:2807-2811
20. Lee C-W, Rivera R, Dubin AE, Chun J (2007) LPA4/GPR23 is a lysophosphatidic acid (LPA) receptor utilizing Gs-, Gq/Gi-mediated calcium signaling and G12/13-mediated rho activation. J Biol Chem 282:4310-4317
21. Lin M-E, Herr DR, Chun J (2010) Lysophosphatidic acid (LPA) receptors: signaling properties and disease relevance. Prostaglandins Other Lipid Mediat 91:130-138
22. Ma L, Matsumoto M, Xie W, Inoue M, Ueda H (2009a) Evidence for lysophosphatidic acid 1 receptor signaling in the early phase of neuropathic pain mechanisms in experiments using Ki-16425, a lysophosphatidic acid 1 receptor antagonist. J Neurochem 109:603-610
23. Ma L, Uchida H, Nagai J, Inoue M, Chun J, Aoki J, Ueda H (2009b) Lysophosphatidic acid-3 receptor-mediated feed-forward production of lysophosphatidic acid: an initiator of nerve injury-induced neuropathic pain. Mol Pain 5:64
24. Ma L, Nagai J, Ueda H (2010a) Microglial activation mediates de novo lysophosphatidic acid production in a model of neuropathic pain. J Neurochem 115:643-653
25. Ma L, Uchida H, Nagai J, Inoue M, Aoki J, Ueda H (2010b) Evidence for de novo synthesis of lysophosphatidic acid in the spinal cord through phospholipase A2 and autotaxin in nerve injury-induced neuropathic pain. J Pharmacol Exp Ther 333:540-546
26. Ma L, Nagai J, Sekino Y, Goto Y, Nakahira S, Ueda H (2012) Single application of A2 NTX, a botulinum toxin A2 subunit, prevents chronic pain over long periods in both diabetic and spinal cord injury-induced neuropathic pain models. J Pharmacol Sci 119:282-286
27. Ma L, Nagai J, Chun J, Ueda H (2013) An LPA species (18:1 LPA) plays key roles in the self-amplification of spinal LPA production in the peripheral neuropathic pain model. Molecular pain 9:29
28. Mills GB, Moolenaar WH (2003) The emerging role of lysophosphatidic acid in cancer. Nat Rev Cancer 3:582-591
29. Morishige J-I, Urikura M, Takagi H, Hirano K, Koike T, Tanaka T, Satouchi K (2010) A clean-up technology for the simultaneous determination of lysophosphatidic acid and sphingosine-1-phosphate by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry using a phosphate-capture molecule, Phos-tag. Rapid Commun Mass Spectrom 24:1075-1084
30. Noguchi K, Herr D, Mutoh T, Chun J (2009) Lysophosphatidic acid (LPA) and its receptors. Curr Opin Pharmacol 9:15-23
31. Okudaira S, Yukiura H, Aoki J (2010) Biological roles of lysophosphatidic acid signaling through its production by autotaxin. Biochimie 92:698-706
32. Perrin FE, Lacroix S, Avilés-Trigueros M, David S (2005) Involvement of monocyte chemoattractant protein-1, macrophage inflammatory protein-1alpha and interleukin-1beta in Wallerian degeneration. Brain 128:854-866
33. Reeve AJ, Patel S, Fox A, Walker K, Urban L (2000) Intrathecally administered endotoxin or cytokines produce allodynia, hyperalgesia and changes in spinal cord neuronal responses to nociceptive stimuli in the rat. Eur J Pain 4:247-257
34. Samad TA, Moore KA, Sapirstein A, Billet S, Allchorne A, Poole S, Bonventre JV, Woolf CJ (2001) Interleukin-1[beta]-mediated induction of Cox-2 in the CNS contributes to inflammatory pain hypersensitivity. Nature 410:471-475
35. Shan L, Jaffe K, Li S, Davis L (2008) Quantitative determination of lysophosphatidic acid by LC/ESI/MS/MS employing a reversed phase HPLC column. J Chromatogr B 864:22-28
36. Sugiura T, Nakane S, Kishimoto S, Waku K, Yoshioka Y, Tokumura A (2002) Lysophosphatidic acid, a growth factor-like lipid, in the saliva. J Lipid Res 43:2049-2055
37. Sun L, Wu Z, Hayashi Y, Peters C, Tsuda M, Inoue K, Nakanishi H (2012) Microglial cathepsin B contributes to the initiation of peripheral inflammation-induced chronic pain. J Neurosci 32:11330-11342
38. Sung CS, Wen ZH, Chang WK, Chan KH, Ho ST, Tsai SK, Chang YC, Wong CS (2005) Inhibition of p38 mitogen-activated protein kinase attenuates interleukin-1beta-induced thermal hyperalgesia and inducible nitric oxide synthase expression in the spinal cord. J Neurochem 94:742-752
39. Tager AM, LaCamera P, Shea BS et al (2008) The lysophosphatidic acid receptor LPA1 links pulmonary fibrosis to lung injury by mediating fibroblast recruitment and vascular leak. Nat Med 14:45-54
40. Takeda H, Kawasaki A, Takahashi M, Yamada A, Koike T (2003) Matrix-assisted laser desorption/ionization time-of-flight mass spectrometry of phosphorylated compounds using a novel phosphate capture molecule. Rapid Commun Mass Spectrom 17:2075-2081
41. Tanaka T, Tsutsui H, Hirano K, Koike T, Tokumura A, Satouchi K (2004) Quantitative analysis of lysophosphatidic acid by time-of-flight mass spectrometry using a phosphate-capture molecule. J Lipid Res 45:2145-2150
42. Tokumura A, Miyake M, Nishioka Y, Yamano S, Aono T, Fukuzawa K (1999) Production of Lysophosphatidic Acids by Lysophospholipase D in Human Follicular Fluids of In Vitro Fertilization Patients. Biol Reprod 61:195-199
43. Uceyler N, Tscharke A, Sommer C (2007) Early cytokine expression in mouse sciatic nerve after chronic constriction nerve injury depends on calpain. Brain Behav Immun 21:553-560
44. Ueda H (2008) Peripheral mechanisms of neuropathic pain - involvement of lysophosphatidic acid receptor-mediated demyelination. Mol Pain 4:11
45. Ueda H, Ueda M (2011) Lysophosphatidic acid as an initiator of neuropathic pain: biosynthesis and demyelination. Clin Lipidol 6:147-158
46. Ueda H, Matsunaga H, Olaposi OI, Nagai J (2013) Lysophosphatidic acid: chemical signature of neuropathic pain. Biochim Biophys Acta 1831:61-73
47. van Corven EJ, Groenink A, Jalink K, Eichholtz T, Moolenaar WH (1989) Lysophosphatidate-induced cell proliferation: identification and dissection of signaling pathways mediated by G proteins. Cell 59:45-54
48. Walters JN, Bickford JS, Beachy DE, Newsom KJ, Herlihy JD, Peck MV, Qiu X, Nick HS (2011) cPLA(2)alpha gene activation by IL-1beta is dependent on an upstream kinase pathway, enzymatic activation and downstream 15-lipoxygenase activity: a positive feedback loop. Cell Signal 23:1944-1951
49. Wolf G, Livshits D, Beilin B, Yirmiya R, Shavit Y (2008) Interleukin-1 signaling is required for induction and maintenance of postoperative incisional pain: genetic and pharmacological studies in mice. Brain Behav Immun 22:1072-1077
50. Xu YJ, Aziz OA, Bhugra P, Arneja AS, Mendis MR, Dhalla NS (2003) Potential role of lysophosphatidic acid in hypertension and atherosclerosis. Can J Cardiol 19:1525-1536
51. Zhao Y, Natarajan V (2013) Lysophosphatidic acid (LPA) and its receptors: role in airway inflammation and remodeling. Biochim Biophys Acta 1831:86-92 Technology Technology